TNFSF10 and malignant colon neoplasm: Cell death by apoptosis at these conditions is significantly facilitated when TRAIL is concomitantly administered, as compared to the innate sensitivity to TRAIL in colon cancer cells bearing a single BRAFV600E mutation.